Clinical Trial

Universal CAR-T Cell Therapy for MM

Name: Universal CAR-T Cell Therapy for MM — clinical trial record (NCT07248176)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This trial aims to evaluate the safety and efficacy of BCMA-UCART in treating patients with r/r multiple myeloma.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-18.

Trial Details

NCT Number	NCT07248176
Lead Sponsor	Bioray Laboratories Collaborators: Shanghai Tongji Hospital, Tongji University School of Medicine
Conditions	Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Enrollment	6 participants
Start Date	2025-04-10
Primary Completion	2027-03-15 (estimated)
Study Completion	2028-04-18 (estimated)
Updated on ClinicalTrials.gov	2025-12-01